RHO-KINASE INHIBITORS
Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.
1 . A compound of formulae I-VI
or a pharmaceutically acceptable salt thereof.
2 . A compound of claim 1 , of formula I
3 . A compound of claim 1 , of formula II
4 . A compound of claim 1 , of formula III
5 . A compound of claim 1 , of formula IV
6 . A compound of claim 1 , of formula V
7 . A compound of claim 1 , of formula VI
8 . A method of treating an indication mediated by Rho-kinase, comprising administering to a host in a need thereof a compound of claim 1 .
9 . A method of treating hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, neuronal degeneration, spinal cord injury, cancer of the breast, colon, prostate, ovaries, brain or lung, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction, comprising administering to a host in need thereof a compound according to claim 1 .
10 . A method according to claim 8 , wherein the host is a human.
11 . A method according to claim 9 , wherein the host is a human.
12 . A method for the preparation of a compound as to claim 1 , comprising
(a) reacting compound of formula 1 with a compound of formula 2, in the presence of a base, to produce a compound of formula 3
wherein R 1 and R 2 can independently be hydrogen or CH 3 O—, and Ph is phenyl, and
(b) optionally, reacting a compound of formula 3 with R 3 NH 2 or Ar 2 NH 2 to produce a compound of formula 4
wherein R 3 is CH 3 O—CH 2 CH 2 —, or cyclopropyl, and Ar 2 is 4-fluorophenyl or pyridyl.